Drug delivery devices have provided many benefits to the healthcare industry. These devices are uniquely designed to efficiently deliver drugs and other therapeutics through a specific route of administration. This category icludes devices such as metered-dose inhalers, eye and ear droppers, infusion pumps and multi-use auto-injectors, among others. Additionally these devices can serve to minimize errors that may occur with more manual delivery procedures.
A prominent category of drug delivery devices are multiple-use devices where they are intended to be used by either one patient multiple times or used on multiple patients. With all the benefits multi-use drug delivery devices provide, they also create another source for potential cross-contamination and infection. If these devices are not properly cleaned prior to and after use, or if they are accessed incorrectly, they may become a breeding ground for pathogens. Similar to other devices that have been implemented in hospital settings, these multi-use delivery devices need to be protected.
Agion® Antimicrobial can be compounded into the housing material, or applied as a coating to these devices to provide a “built-in” protection against the growth of microbes over the intended life of the device. Agion is effective against a broad spectrum of clinically relevant microbes, including multi-drug resistant organisms that are responsible for the most severe healthcare-associated infections.
For more information about Sciessent and how we can improve your implantable devices, please feel free to contact us.
The Agion® Antimicrobial is presently registered by the United States Environmental Protection Agency as a preservative and bacteriostatic agent for use in treated articles under 40 CFR 152.25a. The information presented herein is not intended to support or endorse public health claims for treated articles. The Agion Antimicrobial is also used in medical devices under the Food and Drug Administration in the US; those medical device claims are based on safety and efficacy testing and are limited to those approved by FDA. In the EU, the Agion Antimicrobial is used in medical devices under the Medical Device Directive: those medical device claims are based on safety and efficacy testing and are limited to those approved by the designated Competent Authorities and/or Notified Bodies.